The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dement'eva I.I.

RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Charnaia M.A.

RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Morozov Iu.A.

RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

The first experience of domestic recombinant factor VIIa (Coagil-VII) using for massive refractory bleeding in cardiac surgery

Authors:

Dement'eva I.I., Charnaia M.A., Morozov Iu.A.

More about the authors

Read: 980 times


To cite this article:

Dement'eva II, Charnaia MA, Morozov IuA. The first experience of domestic recombinant factor VIIa (Coagil-VII) using for massive refractory bleeding in cardiac surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(3):74‑75. (In Russ.)

Recommended articles:
Risk factors of severe chylothorax after cardiac surgery in children. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):526-533
Intraoperative left ventricular rupture in cardiac surgery. Piro­gov Russian Journal of Surgery. 2025;(4):95-99
Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80
Risk factors for postoperative bleeding after tonsillectomy. Systematic review. Russian Bulletin of Otorhinolaryngology. 2025;(5):94-99
Intraopertive use of local hemo­statics in infe­cted wounds. Piro­gov Russian Journal of Surgery. 2025;(11):94-100

References:

  1. Gladysheva V.G., Dement'eva I.I., CHarnaya M.А., Morozov YU.А. Izmenenie pokazatelej sistemy gemostaza pri terapii rekombinantnym aktivirovannym faktorom svertyvaniyaVIIa [The change of parameters of the hemostatic system during therapy with recombinant activated coagulation factor VIIa]. Vestn inten ter 2005; 1: 3-4. (in Russian)
  2. Dement'eva I.I., Gladysheva V.G., Morozov YU.А., CHarnaya M.А. Vliyanie preparata "NovoSehven" na ob"em gemotransfuzij u kardiokhirurgicheskikh bol'nykh s povyshennoj krovotochivost'yu nekhirurgicheskogo geneza [Effect of the drug "NovoSeven" on the volume of blood transfusion in cardiac surgery patients with bleeding of nonsurgical genesis]. Vestn inten ter 2005; 3: 59-61. (in Russian)
  3. Dement'eva I.I., Gladysheva V.G., Morozov YU.А., CHarnaya M.А. Primenenie rekombinantnogo aktivirovannogo faktora VII v obshhekhirurgicheskoj praktike [Use of recombinant activated factor VII in general surgical practice]. Vestn khir 2005; 5: 103-106. (in Russian)
  4. Dement'eva I.I., Gladysheva V.G., CHarnaya M.А., Morozov YU.А. K voprosu o bezopasnosti i ehffektivnosti ispol'zovaniya rekombinantnogo aktivirovannogo faktora VIIa pri lechenii massivnykh nekontroliruemykh krovotechenij [On the question of the safety and efficacy of recombinant activated factor VIIa in the treatment of massive uncontrolled bleeding]. Vestn inten ter 2005; 4: 84-86. (in Russian)
  5. Dement'eva I.I., Gladysheva V.G., CHarnaya M.А., Morozov YU.А. O mekhanizme dejstviya rekombinantnogo aktivirovannogo faktora VII pri massivnykh krovotecheniyakh negemofil'noj prirody u kardiokhirurgicheskikh bol'nykh [The mechanism of action of recombinant activated factor VII in non-hemophilic massive bleeding in cardiac patients]. Vestn RАMN 2006; 12: 21-25. (in Russian)
  6. Dement'eva I.I., Eremenko А.А., CHarnaya M.А. i dr. Ispol'zovanie rekombinantnogo aktivirovannogo faktora VIIa v khirurgicheskoj praktike (posobie dlya vrachej) [Use of recombinant activated factor VIIa in surgery (manual for physicians)]. M: MАKS Press 2006. (in Russian)
  7. Dement'eva I.I., Sandrikov V.А., CHarnaya M.А. i dr. Ispol'zovanie gemostatika NovoSehven (rFVIIa) u bol'nykh, operirovannykh v usloviyakh iskusstvennogo krovoobrashheniya [Using Antihemorrhagics NovoSeven (rFVIIa) in patients operated under cardiopulmonary bypass]. Аnesteziol i reanimatol 2004; 5: 11-14. (in Russian)
  8. Dement'eva I.I., CHarnaya M.А., Morozov YU.А. Sistema gemostaza pri operatsiyakh na serdtse i magistral'nykh sosudakh [Hemostatic system during operations on the heart and great vessels]. M: GEHOTАR-Media 2009. (in Russian)
  9. Dement'eva I.I., CHarnaya M.А., Morozov YU.А., Trekova N.А. Ispol'zovanie gemostatika NovoSehven® u bol'nykh s massivnoj gemorragiej pri krupnykh khirurgicheskikh vmeshatel'stvakh [Using Antihemorrhagics NovoSeven ® in patients with massive hemorrhage in major surgery]. Posobie dlya vrachej. M: MАKS Press 2004. (in Russian)
  10. Samsonova N.N., Kim А.I., Plyushh M.G. i dr. Profilaktika I korrektsiya gemorragicheskikh oslozhnenij u kardiokhirurgicheskikh bol'nykh s ispol'zovaniem novykh tekhnologij [Prevention and correction of bleeding complications in cardiac patients by using of new technologies]. Probl gematol 2004; 1: 38-40. (in Russian)
  11. SHulutko E.M., Galstyan G.M., SHHerbakova O.V. i dr. Klinicheskoe primenenie preparata "NovoSehven" u vzroslykh s trombotsitopenicheskim gemorragicheskim sindromom [The clinical use of the drug "NovoSeven" adults with thrombocytopenic hemorrhagic syndrome.]. V kn: Primenenie preparata "NovoSehven" v lechenii gemorragicheskogo sindroma, vyzvannogo trombotsitopeniej. M: MАKS Press 2004; 52-65. (in Russian)
  12. Niles S.D., Burkhart H.M., Duffey D.A. et al. Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery. J Extra Corpor Technol 2008; 40: 4: 241-248.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.